Gastroenterology

Photoimmune Therapy: Possible Treatment for Refractory Crohn’s Disease?

Christopher Kong
Christopher Kong, Glasgow Royal Infirmary
British Society of Gastroenterology Annual Meeting. Birmingham, March 20-23, 2006
A combination of a drug and an photophoresis machine has been used in an attempt to inactivate white cells among patients with Crohn’s disease. The experimental treatment uses the combined action of methoxypsoralen and ultra-violet light to produce a biological effect which could benefit patients whose Crohn’s disease is refractory to other forms of treatment. At the British Society of Gastroenterology Annual Meeting held in Birmingham Christopher Kong presented early data from a group of five patients receiving what is called photoimmune therapy.

Similar Interviews

  • Audio Journal of Gastrointestinal Cancer Special Edition 2005
  • Reporting from: - Gastrointestinal Cancers Symposium, January 27-29, 2005, Hollywood, Florida In this edition: Bruce Giantonio and Robert Mayer discuss the Eastern Cooperative

  • Audio Journal of Oncology in Advance - May 15th, 2007 - reporting from: American Association for Cancer Research, April 14-18, 2007, Los Angeles, CA
  • Alberto Sobrero Cetuximab With Irinotecan: Phase III Study Shows Benefit in Patients with Oxaliplatin-Refractory Colorectal Cancer

  • Audio Journal of Oncology 13.8, December 2005
  • Reporting from: ECCO-13 The European Cancer Conference, Paris, October 30–November 3, 2005 In this edition: Martine Piccart gave the Paris ECCO conference her

    Post a comment

    Subscribe to Audio Medica Podcast